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Objectives: To locate a plant with suitable phytochemicals for use as antimi-
crobial agents to control multidrug-resistant (MDR) bacteria as a complementary
medicine, without host toxicity as monitored through cultured lymphocytes from
human umbilical cord blood.
Methods: The methanol crude leaf extract of the plantWoodfordia fruticosa was
subjected to antimicrobial assay in vitro with nine pathogenic MDR bacteria from
clinical samples. This was followed by bioassay-guided fractionation with seven
non-polar to polar solvents, gas chromatographyemass spectrometry analysis of
the n-butanol fraction, and monitoring of the host toxicity of the leaf extract
with in vitro grown lymphocytes from human umbilical cord blood.
Results: The leaf extract of W. fruticosa had a controlling capacity for MDR
bacteria. The minimum inhibitory concentration and minimum bactericidal
concentration of the n-butanol fraction were < 1.89 mg/mL extract and 9.63 mg/
mL extract, respectively. The gas chromatographyemass spectrometry spectrum
of the n-butanol fraction confirmed the presence of 13 peaks of different com-
pounds with retention times of 9.11 minutes, 9.72 minutes, 10.13 minutes, 10.78
minutes, 12.37 minutes, 12.93 minutes, 18.16 minutes, 21.74 minutes, 21.84
minutes, 5.96 minutes, 12.93 minutes, 24.70 minutes, and 25.76 minutes. The six
leading compounds were: diethyl phthalate: IUPAC name: diethyl benzene-1,2-
dicarboxylate; 5-methyl-2-(1-methylethyl) phenol: IUPAC name: 5-methyl-2-4@yahoo.com (R.N. Padhy).
ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
) which permits unrestricted non-commercial use, distribution, and reproduction in any
operly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
Antibacterial Activity of Woodfordia fruticosa 299propan-2-ylphenol; (E )-3,7-dimethylocta-2,6-diene-1-thiol: IUPAC name: (2Z)-
3,7-dimethylocta-2,6-diene-1-thiol; 2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-,
(E,E ): IUPAC name: 2,6,10-dodecatrien-1-ol; 3,7,11-trimethyl-, (E,E); 2-
methoxy-4-(2-propenyl) phenol: IUPAC name: 2-methoxy-4-[(1E)-prop-1-en-1-yl]
phenol; hexadecanoic acid: IUPAC name: hexadecanoic acid.
Conclusion: The presence of antimicrobial compounds that are therapeutically
potent against MDR bacteria was confirmed in W. fruticosa. The crude leaf
extract showed no host toxicity with human lymphocytes; the n-butanol fraction
of the extract was the most suitable bioactive fraction. The terpenes isolated
were: 5-methyl-2-(1-methylethyl) phenol, 2-methoxy-4-(2-propenyl) phenol,
2,6-octadien-1-ol, 3,7-dimethyl-(E )-2,6-octadienal, 3,7-dimethylcyclohexanol,
and cyclohexanol, 2-methylene-5-(1-methylethenyl) which were reported to
have specifically antimicrobial activity.1. Introduction
Several plant species have been used by many gen-
erations of local ethnic tribes, especially those of the
Kalahandi District, Odisha, India for holistic health care
[1]. This practice has been validated by the Indian ay-
urvedic school, Indian traditional medicine, and Indian
folklore medicine for several hundred plants [2]. In
addition, a number of crude drugs known as aristha and
asava are prepared, marketed, and consumed by much
of the Indian population.Woodfordia fruticosa has many
ethno-botanical roles as a traditional medicine, such as
curing bowel disorders, dysentery, diarrhea, ulcers, and
other infectious diseases, in addition to treating rheu-
matism [3e5]. This plant can cure peptic ulcers induced
by Helicobacter pylori [6]. Therefore it was thought to
be worthwhile to study its antibacterial activity against
bacterial pathogens from clinical samples.
Infection and morbidity as a result of multidrug-
resistant (MDR) bacteria in both community and
hospital settings has been a problem for many decades e
for example, methicillin-resistant Staphylococcus
aureus (MRSA) is currently resistant to 23 antibiotic
drugs [7]. Other pathogenic bacteria, such as various
species of Acinetobacter, Pseudomonas, and Klebsiella
have developed clonal nexuses so much that these,
mainly Gram-negative, bacteria have been recorded as
potent MDR bacteria in nosocomial surveys of patients
in our hospital over the past 5 years [8e10]. The effect
of MDR bacterial pathogens can be illustrated by the
example of urinary tract infections (UTIs), which are
common infections affecting > 50% of the population at
some time in their life. UTIs are treated empirically with
an antimicrobial stewardship program, but when the
causative bacteria in repeated infections are found to be
MDR, the failure of the empirical treatment can be
devastating [9]. A patient with a UTI may initially have
cystitis, which, if neglected or if the empirical treatment
fails, leads to kidney infection (pyelonephritis). Ulti-
mately, the infection may spread to other vulnerable
zones such as the heart and lungs. This may cause a
cough and an infection spread via the bloodstream fromthe kidneys may lead to endocarditis and terminal res-
piratory tract infections. To overcome this snowball
effect of a UTI infection, in addition to mainstream
treatment with antibiotic drugs, the use of a medicine
from a complementary/supplementary source might be a
prudent approach in view of the thousands of published
research papers claiming that medicinal plants may have
antimicrobial activities [1].
The resistant, or rather non-committal, attitude of
mainstream medicinal practices has restrained the use of
plethora of natural compounds from plant sources [11].
However, the most obvious method of treating a bac-
terial infection is to use antibiotics from microbes, i.e.,
from organisms with a similar heritage. If scaled up,
crude plant extracts could be fractioned and the active
antimicrobial fraction could be isolated and used as a
complementary medicine together with the prescribed
mainstream drug to control infectious diseases because
no microbe, however well-equipped genetically by
multidrug-resistance, can win over an array of
phytocompounds.
This paper describes the antibacterial activities of
crude leaf extracts of W. fruticosa and its fractions
extracted using seven non-polar and polar solvents. The
best solvent fraction was used to determine the mini-
mum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) values against MDR
strains of nine pathogenic bacteria isolated from clinical
samples. This work is better than other antimicrobial
work with plants with standard bacterial reference
strains from culture centers with undefined antibiotic
sensitivity patterns of used bacteria, available in litera-
ture. The best solvent fraction was used for gas chro-
matographyemass spectroscopy (GC-MS) analysis to
locate lead compounds that could be the coveted anti-
microbial agents. The crude plant extract was tested for
possible host toxicity by monitoring its activity against
lymphocytes grown in vitro from human umbilical cord
blood. The use of a bioactive fraction of a leaf extract of
a plant without any host toxicity as a complementary
antimicrobial agent for use alongside an antibiotic drug
would be a novel approach against MDR bacteria.
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2.1. Collection of plant material and
preparation of plant fractions
A methanolic extract was obtained from the dried
leaf powders of W. fruticosa Kurz. via a 24-hour hot
extraction method using a Soxhlet apparatus
(Figure 1). The extract was filtered and the filtrate
dried in vacuo. The crude methanol extract was sub-
jected to a bioassay-guided fractionation by solubiliz-
ing in water followed by sequential partition with n-
hexane, chloroform, ethyl acetate, dichloromethane,
and n-butanol. The end product is referred to as the
methanol fraction. Each collected fraction was
concentrated under reduced pressure to form a dark
residue.2.2. Isolation and identification of pathogenic
bacteria
Bacterial strains were isolated from clinical samples
(urine, pus, swabs, or blood samples) from patients
admitted to different wards of the hospital, including
intensive care and neonatal intensive care units, wards,
and cabins. The samples were cultured on suitable agar
media and the bacterial isolates were identified using
VITEK2 (Bimereux, New Delhi, India) and standard
biochemical procedures following the Clinical and
Laboratory Standards Institute (CLSI) guidelines [12].
Standard microbial type culture collection (MTCC),
Chandigarh strains of bacteria were used as reference
controls. Three Gram positive bacteria [MRSA,
Streptococcus pyogenes, and vancomycin-resistant
Enterococcus faecalis (VRE)] and six Gram-negative
extended spectrum beta lactamase (ESBL) producing
strains of bacteria (Acinetobacter baumannii, Klebsi-
ella pneumoniae, Proteus vulgaris, Pseudomonas aer-
uginosa, Citrobacter freundii, and Proteus mirabilis)
were isolated and used in this study.Figure 1. Woodfordia fruticosa Kurz.2.3. Antibiotic susceptibility test
All of the nine bacterial strains used were subjected
to an antibiotic sensitivity test using the KirbyeBauer
method or the disc diffusion method [13].
2.4. MRSA, vancomycin-resistant S. pyogenes,
E. faecalis, and ESBL production
The isolated strains of S. aureus, S. pyogenes, and E.
faecalis were subjected to the chromogenic agar media
test and vancomycin screen agar plate test to confirm
their MRSA and vancomycin-resistant S. pyogenes and
Enterococcus (VRE) status, respectively [14]. Similarly,
to determine the ESBL producers in the remaining six
Gram negative bacteria, the double disc synergy test was
used [8].
2.5. Antibacterial activity test by agar-well
diffusion method
The antibacterial activities of the seven different
solvent fractions (Merck, Mumbai, India; HiMedia,
Mumbai, India; Sigma-Aldrich, Mumbai, India.) were
determined using the agar-well diffusion method [14].
Linezolid (30 mg/mL) and imipenem (10 mg/mL) were
used as reference controls for the Gram-positive and
Gram-negative bacterial work, respectively. All the
Gram-negative bacteria were ESBL producers; of the
three Gram-positive bacterial species, S. aureus was
MRSA and another two were resistant to vancomycin.
2.6. Determination of MIC and MBC
The MIC and MBC of the active n-butanol fraction
were determined as described previously [13].
2.7. GCeMS analysis
The GC-MS analysis of the n-butanol fraction was
carried out using an instrument equipped with a VF-
5 ms fused-silica capillary column of 30 m length,
0.25 mm diameter, and 0.25 mm film thickness. An
electron ionization system with an ionization energy of
70 eV was used as the detector. Helium gas (99.99%)
was used as the carrier gas at the constant flow-rate of
1.51 mL/minute. The temperatures of the injector and
mass transfer line were set at 200C and 240C,
respectively. The oven temperature was programmed
from 70C to 220C at 10C/minute, held constant for 1
minute and finally increased to 300C at 10C/minute.
Aliquots of 2 mL of the diluted samples were manually
injected in the split-less mode with a split ratio of 1:40
and with a mass scan range of 50e600 AMU. The total
running time of the GCeMS analysis was 60 minute.
2.8. Identification of compounds
The phytochemical components of the biologically
active fraction (the n-butanol fraction) were identified
by comparing their mass spectra fragmentations and
retention indices with those stored in the following da-
tabases: NIST08.LIB (Stein SE National Institute of
Antibacterial Activity of Woodfordia fruticosa 301Standards and Technology, Mass Spectral Database and
Software.Version 3.02, NIST, Gaithersburg, Md, USA,
1990) and WILEY8.LIB [15], and also with published
data.
2.9. Toxicity testing of crude plant extract with
lymphocytes grown in vitro from human
cord blood monitored by the AO/EB
staining method
2.9.1. Collection of lymphocytes
Umbilical cord blood (UCB) was collected in a
sterile 15- or 50-mL sized Falcon tube (Tarson, Kolkata,
India) with an aliquot of 100 mL or 250 mL of 1000 IU
heparin (HiMedia, Mumbai, India), immediately after
the delivery of an infant. The blood sample
(<15e50 mL) was stored at 4C until use. Lymphocytes
were isolated immediately or within 24 hours of
collection. To isolate the lymphocytes, the collected
UCB sample was diluted with an equal volume of
phosphate-buffered saline (PBS) solution. The mixture
was then loaded carefully into a centrifuge tube for
over-layering with lymphocyte separating medium
(HiMedia), which was one-third the total volume of the
mixture. The mixture was centrifuged at 1800  g for 25
minutes at 22e24C. Four heavy to light layers (red
blood cells, lymphocyte separating medium, buffy coat,
and plasma) were seen. The buffy coat layer with
mononuclear cells was carefully removed from the tube.
After the addition of another aliquot of PBS to the
separated cells of the buffy coat layer at a ratio of 1:1,
the sample was centrifuged again at 2000  g for 5
minutes. The lymphocyte pellet was cultured and the
cells were counted using a haemocytometer [15].
2.9.2. Growth of lymphocytes
After separation, the lymphocytes derived from UCB
were diluted to a density of 1  106 cells/mL with the
required volume of Dulbecco’s Modified Eagle’s Me-
dium (DMEM, low glucose; HiMedia) and were loaded
into a six-well culture plate (Tarson) containing 15%
fetal bovine serum (Sigma, Sigma-Aldrich, Mumbai,
India), 1% penicillinestreptomycin, and 1% sodium
pyruvate, along with graded concentrations of plant
extract for the in vitro growth of lymphocytes. The stock
solution was prepared by dissolving 100 mg of plant
extract in an aliquot of 100 mL of triple-distilled water
to give a concentration of 1000 mg/L and the stock
solution was stored at 4C for further use. A total vol-
ume of 2 mL was maintained in each well of the culture
plate using the plant extract solution. The cells were
incubated with different concentrations of plant extract
(0 mg/L, 20 mg/L, 40 mg/L, 60 mg/L, 80 mg/L, 100 mg/
L, 120 mg/L, 140 mg/L, 160 mg/L, 180 mg/L, 200 mg/
L, 220 mg/L, 240 mg/L, 260 mg/L, 280 mg/L, and
300 mg/L) and grown in an incubator at 37C in an
atmosphere of 5% CO2 for 24 hours [15].2.9.3. Monitoring toxicity with lymphocytes
The viability of lymphocytes grown in the presence
of graded concentrations of plant extract was determined
by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoli-
um bromide (MTT) assay. The MTT solution was pre-
pared at a concentration of 5 mg/mL in PBS. After 24
hours of plant extract treatment in six-well culture plate,
80 mL of MTT solution were added to each well to study
the toxicity effect. The plate was stored in an incubator
(37C, 5% CO2) for 4 hours. It was found that the media
containing the cells and a toxin changed to a blue color
after incubation with MTT. The samples were then
gently centrifuged at 1000 rpm = 157  g for 10 minute
at 22C. The supernatant was removed and the pellet
was dissolved in 1 mL of 100% dimethyl sulfoxide
(DMSO) and stored in the incubator for 1 hour. A purple
color was seen. The optical density was measured with a
spectrophotometer at 570 nm [16]:
Percentage of cell densityZ100 ðODsample ODblank

ð1Þ
MTT in DMSO solution was taken as the blank.
Probits of the observed lethality percentage were used
for the analysis of toxicity.
2.9.4. Comet assay
Lymphocytes were cultured with different concen-
trations of the plant extract and the DNA damage in the
harvested cells were determined by the neutral comet
assay. Slides were coated with 1% agarose and allowed
to dry in air. The lymphocyte pellets obtained by
centrifugation of the cultured cells were washed with
PBS and the pellet was mixed with three times the cell
volume of the pellet with low melting point agarose 1%
in a sol state. The mixture of cells and low melting point
agarose sol was placed over the agarose-coated slide,
which was then kept at 4C for 10 minutes until dry. The
dried slides were submerged into a pre-cooled lysing
solution of 2.5 M NaCl, 100 mM EDTA, 10 mM pH 7.4
Tris, 1% Triton-X 100, and 10 mM dithiothreitol. The
mixture was stored at 4C in the dark for about 2 hours.
The slides were subsequently removed and placed in an
electrophoresis buffer with 500 mM NaCl, 100 mM
Tris, 1 mM EDTA, and 0.2% DMSO, for 20 minutes.
The slides were transferred to a horizontal gel electro-
phoresis chamber with fresh electrophoretic buffer.
Electrophoresis was carried out at 10 V and 250 mA for
60 minutes. After electrophoresis the slides were washed
in PBS for 5 minutes and placed in a neutralizing so-
lution with 50% ethanol and 20 mM Tris for 5 minutes,
then washed again in PBS. After 5 minutes the slides
were stained with ethidium bromide solution. The slides
were observed under a fluorescence microscope at
400  magnification and the comets were scored.
Probits of observed lethality percentage values calcu-
lated from the percentage values of observed comets due
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co3. Results
3.1. Antibiotic susceptibility of isolated
bacteria
Antibiotic susceptibility tests for three Gram-
positive and six Gram-negative bacterial isolates were
carried out; 18 antibiotics from seven groups were used
against Gram-positive bacteria; 16 of 18 antibiotics
(except oxacillin and vancomycin) were used against
the Gram-negative bacteria. The MRSA strain was
found to be sensitive to two antibiotics (ciprofloxacin
and chloramphenicol), but was resistant to the other 16
antibiotics. Similarly, A. baumannii was resistant to 14
antibiotics and was sensitive to two antibiotics (genta-
micin and chloramphenicol). Antibiograms of other
three Gram-positive bacteria and five Gram-negative
bacteria were recorded (Table 1). All the isolated
Gram-negative bacteria were also ESBL producers.
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co3.2. Antibacterial activities of the seven solvent
fractions
The antibacterial activities of the seven solvent
fractions were monitored by the agar-well diffusion
method on separate lawn cultures of nine bacterial
isolates (3 Gram-positive and 6 Gram-negative bacte-
ria). The n-butanol leaf fraction of W. fruticosa regis-
tered the maximum diameter of the size zone of
inhibition against MRSA (37 mm), followed by C.
freundii (33 mm). The methanolic fraction registered
the maximum size of zone inhibition against MRSA
(30 mm). The n-hexane and dichloromethane fractions
registered very low antibacterial activity compared
with the other five solvent fractions. The antibacterial
activities of all the other fractions were recorded
(Table 2).T
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The MIC and MBC values of the n-butanol fraction
were determined as it registered the maximum level of
antibacterial activity. An MIC value of 0.37 mg/mL of
the n-butanol fraction was recorded against MRSA, S.
pyogenes, and C. freundii; a value of 0.141 mg/mL was
recorded against A. baumannii. An MIC value of
1.89 mg/mL was recorded against P. mirabilis and P.
aeruginosa, while 0.83 mg/mL was the MIC value
against VRE and P. vulgaris (Table 3). An MBC value
of 1.89 mg/mL of the n-butanol fraction was registered
against MRSA, S. pyogenes, A. baumannii, and C.
freundii; a value of 4.27 mg/mL was registered against
VRE, whereas P. mirabilis, P. vulgaris, and P. aeru-
ginosa had an MBC value of 9.63 mg/mL (Table 3).
Table 2. Antibacterial assay by agar-well diffusion method of hot solvent leaf extract fractions of Woodfordia fruticosa
against MDR strains of bacteria.a
Bacteria n-Hexane Chloroform
Ethyl
acetate Dichloromethane Acetone Butanol Methanol
Linezolid/imipenem
(30/10 mg/mL)
Methicillin-resistant
Staphylococcus
aureus
10 21 23 29 23 37 30 29
Streptococcus
pyogenes
15 22 19 19 18 26 26 29
VRE 17 15 19 25 26 29 29 33
Acinetobacter
baumannii
8 12 22 19 13 28 26 31
Citrobacter freundii 11 18 24 23 19 33 30 26
Proteus mirabilis 10 19 23 29 19 23 22 29
Proteus vulgaris 18 18 25 19 15 32 26 26
Pseudomonas
aeruginosa
9 23 22 25 19 34 27 29
aResults given as diameter of the zone of inhibition (mm).
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The phytochemical screening of the n-butanol leaf
fraction of W. fruticosa revealed the presence of alka-
loids, glycosides, terpenoids, steroids, saponins, and
tannins. The results of the GC-MS analysis led to the
identification of different compounds from the n-butanol
fraction (Figure 2). The structures of the compounds
were based on the analysis of the fragmentation pattern
of the mass spectra, a direct comparison of their spectral
data with the chemical profiles in the National Institute
of Standards and Technology (NIST) library, Gaithers-
burg, Md,D, USA, and comparisons with published
mass spectra.
The chemical profiles of the identified compounds,
together with their retention time, percentage peak area,Table 3. Minimum inhibitory concentration and mini-
mum bactericidal concentration of the best
bioactive n-butanol fraction of Woodfordia
fruticosa against multidrug-resistant bacterial
strains (mg/mL).
Strain
n-Butanol
MIC MBC
Methicillin-resistant
Staphylococcus
aureus
0.37 1.89
Streptococcus pyogenes 0.37 1.89
VRE 0.83 4.27
Acinetobacter
baumannii
0.14 1.89
Citrobacter freundii 0.37 1.89
Proteus mirabilis 1.89 9.63
Proteus vulgaris 0.83 9.63
Pseudomonas
aeruginosa
1.89 9.63
MBC Z minimum bactericidal concentration; MIC Z Minimum
inhibitory concentration.molecular formula, molecular weight, structure, nature
of compound, and reported activity are given in Table 4.
The studies of the biologically active compounds in W.
fruticosa by GCeMS analysis clearly showed the pres-
ence of 13 compounds, namely: (1) diethyl phthalate
(26.77%); (2) 5-methyl-2-(1-methylethyl) phenol
(13.37%); (3) (E )-3,7-dimethylocta-2,6-diene-1-thiol
(10.71%); (4) 2,6,10-dodecatrien-1-ol-3,7,11-trimethyl-
(E,E ) (9.15%); (5) 2-methoxy-4-(2-propenyl) phenol
(3.42%); (6) hexadecanoic acid (2.88%); (7) 1,6-
octadien-3-ol-3,7-dimethyl (1.64%), (8) cyclohexanol,
2-methylene-5-(1-methylethe (1.98%); (9) 2,6-octadien-
1-ol, 3,7-dimethyl-, (E)- (1.97%); (10) 2,6-octadienal,
3,7-dimethyl- (1.84%); (11) 2,6-octadien-1-ol, 3,7-
dimethyl-, acetate, (E)-(1.18%); (12) tetradecanoic
acid (1.00%), benzyl benzoate (1.21%); and (13) 10,12-
hexadecadien-1-ol (1.14%).
The GCeMS spectrum confirmed the presence of 13
peaks of different compounds with retention times of
9.11 minute, 9.72 minute, 10.13 minute, 10.78 minute,
12.37 minute, 12.93 minute, 18.16 minute, 21.74 min-
ute, 21.84 minute, 5.96 minute, 12.93 minute, 24.70
minute, and 25.76 minute, respectively (Figure 3AM).
The mass spectrometer characterized the compounds at
different times to identify the chemical nature and
structure of the eluted compounds. The large compounds
fragment into small compounds giving rise to peaks at
different m/z ratios.3.5. Assessment of plant toxicity
The percentage lethality values recorded from data
sets of the MTT assay and its probit were used to
construct a plot which was then used for extrapolation to
compute the individual lethal concentration (LC) values
(LC25, LC50, and LC75) for each method (Figure 4). The
individual MIC, highest permissive concentration, and
LC100 values were taken directly from the experiments.
Figure 2. Gas chromatographyemass spectrometry chromatogram of the n-butanol fraction of W. fruticosa.
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The cells without a toxin had a higher OD570 value
than the cells treated with different concentrations of
plant extract. The cell density gradually decreased from
20 mg/L to 300 mg/L. Experimentally, the MIC value
for lymphocytes was 20 mg/L. Probit values and log10
values of the concentrations of plant extracts in the plot
yielded log10values for LC25 and LC50 of 1.99 and 2.38,
respectively. These log10 concentration values generated
LC values of 97.72 (LC25) and 239.88 mg/L (LC50)
(Table 5).
3.5.2. Comet assay
Single-cell gel electrophoresis was carried out to
study the DNA damage in cells treated with different
concentrations of plant extract (Figure 5A and B). No
comet was found in the cells treated with different
concentrations of plant extract.4. Discussion
The antibiogram patterns of three Gram-positive
and five Gram-negative bacterial strains clearly indi-
cated resistance to most of the currently used antibi-
otics. In clinical management, this means that a doctor
would not be able to choose an antibiotic to treat a
patient empirically and this scenario of multiple
resistance may cause the bacteria spread in both hos-
pital and community settings. This work clearly indi-
cated that the n-butanol fraction was the leading or
active fraction of the leaf extract and that it could
control eight MDR bacteria. The GCeMS analysis of
the n-butanol fraction of W. fruticosa indicated the
presence of 13 compounds, of which the predominant
compounds were determined.
MRSA strains (40.1% of total isolates) reported from
Nepal were resistant to antibiotics (amikacin, cepha-
lexin, ciprofloxacin, norfloxacin, and trimethoprim/sulfamethoxazole), apart from penicillin derivatives, but
all the strains were vancomycin-sensitive [17]. Dapto-
mycin is now often seen as to be effective against
MRSA [18,19]. In Brazil, urinary and respiratory tract
infections, boils, and surgical wound infections yielded
MRSA at a prevalence of 40e60% in nosocomial set-
tings and the presence of the mecA gene in those strains
was demonstrated [20]. It was reported from Malaysia
that, among 287 bacterial isolates, 45% were Gram-
positive bacteria with S. aureus (40%), group B Strep-
tococci (25%), and Enterococcus sp. (9%); of the rest,
52% were Gram-negative bacterial with Proteus sp.
(25%), P. aeruginosa (25%), K. pneumoniae (15%), and
E. coli (9%). Susceptibility of the Gram-negative bac-
teria to imipenem and amikacin and the Gram-positive
bacteria to vancomycin was recorded [21]. MRSA is
invasive through the eye [22] and by the intravenous
mode [23].
Antibacterial studies of the effect of plant extracts on
non-resistant bacteria have been reported previously
[11]. Long-term hospitalization may lead to extraneous
infection of a patient from MDR bacterial isolates,
particularly MRSA, P. aeruginosa, Klebsiella sp., and
A. baumannii. It was also reported that 51.5% of patients
infected with MRSA had already been infected at the
time of admission to hospital, suggesting the introduc-
tion of a new MRSA strain onto the hospital from the
community [24]. Moreover, in England and Wales,
< 2% of S. aureus strains were methicillin resistant in
1990, but in 2002 about 42% of S. aureus were MRSA.
It has been estimated that 300,000 infections with
MRSA led to 5000 deaths [25]. Nevertheless, vanco-
mycin has always been the drug of choice against
MRSA infections. Our results recorded the isolation of
vancomycin-resistant S. aureus, which has been an
additional clinical problem in this hospital [26]. Com-
plementary medicines are developed on the principle of
“comparative effectiveness research” and isolated
phyto-compounds could be promoted, when the source
Table 4. Phyto-components identified in butanol fraction of leaves of Woodfordia fruticosa.
Peak Retention time (min) Area Area (%) Molecular weight Molecular formula Name Chemical nature Chemical structure
1 9.113 4,131,489 1.98 152 C10H16O Cyclohexanol, 2-methylene-
5-(1-methylethenyl
(Isocarveol)
Monocyclic terpene alcoholic
derivative
2 9.727 4,102,469 1.97 154 C10H18O 2,6-Octadien-1-ol, 3,7-
dimethyl-, (E)-(Geraniol)
Alicyclic monoterpene
alcohol
3 10.136 3,839,900 1.84 152 C10H16O 2,6-Octadienal, 3,7-dimethyl
(Citral)
Alicyclic monoterpene
aldehyde
4 10.783 27,829,208 13.37 150 C10H14O 5-Methyl-2-(1-methylethyl)
phenol (Thymol)
Monocyclic terpene phenol
5 12.374 7,115,681 3.42 164 C10H12O2 2-Methoxy-4-(2-propenyl)
phenol (Eugenol)
Monocyclic terpene phenolic
ether
6 12.937 2,452,534 1.18 196 C12H20O2 2,6-Octadien-1-ol, 3,7-
dimethyl-, acetate, (E)-
(Geranyl acetate)
Alicyclic monoterpene ester
7 18.163 55,723,750 26.77 222 C12H14O4 Diethyl phthalate Diester of phthalic acid
(Continued on next page )
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Table 4 (Continued )
Peak Retention time (min) Area Area (%) Molecular weight Molecular formula Name Chemical nature Chemical structure
8 21.744 2,090,511 1.00 228 C14H28O2 Tetradecanoic acid (Myristic
acid)
Saturated fatty acid
9 21.840 2,509,298 1.21 212 C14H12O2 Benzyl benzoate Aromatic ester
10 5.969 3,421,471 1.64 154 C10H18O 1,6-Octadien-3-ol, 3,7-
dimethyl (Linalool)
Alicyclic monoterpene
alcoholic
11 12.937 2,452,534 1.18 196 C12H20O2 2,6-Octadien-1-ol, 3,7-
dimethyl-, acetate, (E)-
(Geranyl acetate)
Alicyclic monoterpene ester
12 24.702 22,293,627 10.71 170 C10H18S (E)-3,7-dimethylocta-2,6-
diene-1-thiol
(Thiogeraniol)
Alicyclic monoterpene thiol
13 25.764 5,994,750 2.88 256 C6H32O2 Hexadecanoic acid (palmitic
acid)
Saturated fatty acid
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Figure 3. Mass spectra of 13 compounds, with structures as an insert in individual figures. (A) cyclohexanol, 2-methylene-5-(1-
methylethenyl); (B) 2,6-octadien-1-ol, 3,7-dimethyl-, (E)-; (C) 2,6-octadienal, 3,7-dimethyl-; (D) phenol, 5-methyl-2-(1-
methylethyl)-; (E) phenol, 2-methoxy-4-(2-propenyl)-; (F) 2,6-octadien-1-ol, 3,7-dimethyl-, acetate, (E)-; (G) diethyl phthalate;
(H) tetradecanoic acid; (I) benzyl benzoate; (J) 1,6-octadien-3-ol, 3,7-dimethyl; (K) 2,6-octadien-1-ol, 3,7-dimethyl-, acetate, (E)-;
(L) (E)-3,7-dimethylocta-2,6-diene-1-; and (M) hexadecanoic acid.
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Figure 3. (continued)
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Figure 3. (continued)
Figure 4. Probits of the percentage lethality values were plotted against the log10 concentration of plant extracts in the toxicity
study of human lymphocytes.
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Table 5. Probit transformations of percentage lethality values during crude plant extract toxicity to human lymphocytes
growing in Dulbecco’s Modified Eagle’s Medium, assessed by 3-[4, 5-dimethylthiazol-2-yl] 2,5-diphenyl tetrazo-
lium bromide assay.
Concentration of plant
extract (mg/L)
Log10 concentrations of
plant extract OD PL of cells by MTT Assay Probits of MTT Assay
0 e 1.984 0 e
20 1.30 1.861 7.8 3.58
40 1.60 1.843 8.7 3.64
60 1.77 1.619 20.0 4.15
80 1.90 1.619 20.0 4.15
100 2.0 1.541 23.9 4.29
120 2.07 1.432 29.4 4.45
140 2.14 1.376 32.2 4.53
160 2.20 1.210 40.6 4.76
180 2.25 1.143 44.0 4.84
200 2.30 1.101 46.1 4.90
220 2.34 1.087 46.8 4.91
240 2.38 1.004 51.0 5.02
260 2.41 0.987 51.8 5.04
280 2.44 0.922 55.1 5.12
300 2.47 0.845 59.0 5.22
MTT Z 3-[4, 5-dimethylthiazol-2-yl] 2,5-diphenyl tetrazolium bromide; OD Z optical density; PL Z percentage lethality; e Z not applicable.
310 D. Dubey, et alplant has no host toxicity, as seen with W. fruticosa.
There is increasing interest in correlating phytochemical
compounds with their biological activity [27].
In a study from Mysore, India, W. fruticosa was re-
ported to have antibacterial activity against the standard
MTCC strains of the Gram-positive pathogens S. aureus
and Streptococcus faecalis, with a zone of inhibition
> 21 mm, which was larger than the zone of inhibition
of the positive control, the antibiotic gentamicin. In the
same study, the same plant showed a great deal of
antibacterial activity against other standard MTCC
Gram-negative pathogens, particularly against Salmo-
nella paratyphi B, Shigella boydii and Shigella dysen-
teriae [28]. In this study, both standard MTCC strains
and clinical isolates from various sources with different
resistant patterns of the three Gram-positive strains were
used. It was seen that W. fruticosa could control in vitro
the Gram-positive bacteria used.
As an example, crude phyto-extract of a lesser-
known plant, Combretum albidum, has been recorded
having a synergistic effect on the action of theFigure 5. Comet assay with lymphocytes. (A) Control cells;antibiotic ceftriaxone against P. aeruginosa that was
resistant to both ceftriaxone and several other antibi-
otics. The LC25 value of its leaf extract was 97.72 mg/
mL with human lymphocytes and the level of LC50 was
239.88 mg/mL [16]. The LC25 value of the crude
methanol leaf extract at 97.72 mg/L with human
lymphocytes was much greater than the MBC value of
the n-butanol fraction. This study clearly corroborated
the work with the methanol leaf extract of W. fruticosa;
the crude leaf extract of W. fruticosa was non-toxic to
human lymphocytes cultured in vitro. Thus this plant
could possibly help control of MDR pathogens potent
enough cause public health problems. Phyto-
compounds such as alkaloids, glycosides, terpenoids,
steroids, saponins, and tannins were present in the
leaf extract and these compounds have contributed to
the recorded control of MDR bacteria [29]. This
plant could be used as a part of an integrative treatment
of the pathogen as antimicrobial agents of non-
microbial origin along with mainstream antimicrobial
drugs.and (B) cells after treatment with 300 mg/L plant extract.
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fruticosa revealed the presence of a number of second-
ary metabolites that have therapeutic properties, such as
antibacterial, antifungal, antiseptic, anthelmintic, anti-
inflammatory, antihemolytic, anticancer, antioxidant,
antiparasitic, antidiabetic, and wound-healing activities
[30]. The compounds with higher percentages in peak
areas, namely, diethyl phthalate (26.77), 5-methyl-2-(1-
methylethyl) phenol (13.37), dimethylocta-2,6-diene-1-
thiol (10.71), 2-methoxy-4-(2-propenyl) phenol (3.42),
and hexadecanoic acid (2.88) are present in the n-
butanol fraction. These six compounds have previously
been reported to have medicinal properties. Diethyl
phthalate has antimicrobial, acetylcholinesterase, and
neurotoxic activity [31]. The saturated fatty acid, hex-
adecanoic acid, has a wide range of activity, such as
anticancer, antimicrobial, antioxidant, and antihemolytic
activity [32,33]. The monocyclic phenolic compound, 5-
methyl-2-(1-methylethyl) phenol has antibacterial,
antifungal, antiseptic, and antihelmintic activities [34].
The compound 2-methoxy-4-(2-propenyl) phenol, has
been reported to have antibacterial, antimicrobial, anti-
septic, anesthetic, and anticancer properties [35]. The
terpenes isolated in this study consisted of 5-methyl-2-
(1-methylethyl) phenol, 2-methoxy-4-(2-propenyl)
phenol, 2,6-octadien-1-ol, 3,7-dimethyl-(E)-, 2,6-
octadienal, 3,7-dimethyl-, cyclohexanol, 2-methylene-
5-(1-methylethenyl). Terpenes exhibit antimicrobial
activity; the monoterpenes and sesquiterpenes are active
against bacteria and fungi [36]. The terpenes
isolated were 5-methyl-2-(1-methylethyl) phenol, 2-
methoxy-4-(2-propenyl) phenol, 2,6-octadien-1-ol,
3,7-dimethyl-(E)-, 2,6-octadienal, 3,7-dimethyl-, cyclo-
hexanol, 2-methylene-5-(1-methylethenyl), which could
have specific antimicrobial activity.
This study confirms the presence of therapeutically
potent antimicrobial compounds in the n-butanol frac-
tion of the leaf extract of W. fruticosa for the control of
MDR pathogenic bacteria. The crude leaf extract has no
host toxicity with human lymphocytes and the n-butanol
fraction of the extract is the most suitable bioactive
fraction. The antibacterial activity of the n-butanol
fraction could be due to the presence of monoterpenes,
diesters of phthalic acid, saturated fatty acids, and
monocyclic phenolic compounds.Conflicts of interest
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